We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for vosoritide (BioMarin Pharmaceuticals Australia Pty Ltd)
Active ingredients
vosoritide
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection and water for injection
Indication
For the treatment of achondroplasia (ACH)
Therapeutic area
Inherited bone disorder